FN1 and neoplasm: Systemic antibiotic distribution has consistently presented a challenge in clinical practice, particularly due to severe gastrointestinal reactions often associated with intestinal microbiota dysbiosis.[40] As illustrated in Figure 6, while the MTI dose did not achieve complete bacteriostasis of Fn within the tumor microenvironment, it nonetheless significantly disrupted intestinal microbiota homeostasis.